Skip to main content
Elaine Reed, MD, Pathology, Los Angeles, CA

Elaine Frances Reed MD

Pathology•Los Angeles, CA

Clinical Pathology

Physician

Join to View Full Profile

  • UCLA Immunogenetics Department of Pathology UCLALos Angeles, CA 90095

  • Phone+1 310-794-4943

  • Fax+1 310-206-3216

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
Join DoximityAlready have an account?

Summary

  • Dr. Elaine Reed, MD is a pathologist in Los Angeles, California.

Publications & Presentations

PubMed

Press Mentions

  • Patients with a Solid Organ Transplant Have Same Mortality Rates as Other Patients from COVID-19
    Patients with a Solid Organ Transplant Have Same Mortality Rates as Other Patients from COVID-19January 30th, 2025

Grant Support

  • Systems analyses of induction and maintenance of immunity to SARS-CoV-2 vaccination in kidney transplant recipients receiving mycophenolate mofetil immunotherapyUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
  • The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejectionUNIVERSITY OF CALIFORNIA LOS ANGELES2018–2029
  • The role of HLA and its coreceptors in endothelial cell activation and leukocyte recruitment in antibody-mediated transplant rejectionUNIVERSITY OF CALIFORNIA LOS ANGELES2018–2029
  • Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodiesUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
  • Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodiesUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
  • Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodiesUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028
  • Targeting the transcriptional co-activators YAP and TAZ with statins to prevent solid organ transplant rejection by HLA donor specific antibodiesUNIVERSITY OF CALIFORNIA LOS ANGELES2023–2028

Dr. Elaine Reed, Dr. Elaine Reed, MD, Dr. E Reed, Dr. Elaine Frances Reed